Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Samama

Showing results (531-540 of 677) with videos related to

Pageof 68
Sort By:
Revue Des Maladies Respiratoires|November 8, 2005
[Antithrombotic therapy for venous thromboembolism - report of the 7th Conference of The American College of Chest Physicians]A Achkar, M-H Horellou, F Parent, et al.
Annales De Biologie Clinique|October 17, 2001
[Influence of oral anticoagulant treatment on D-dimers levels]E Ombandza-Moussa, M M Samama, M H Horellou, et al.
Anesthesia and Analgesia|May 29, 2001
Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood groupC Huraux, A Ankri A, D Eyraud, et al.
Thrombosis and Haemostasis|October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapyP Y Scarabin, G Plu-Bureau, L Bara, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1995
[Comparison of the effects of ketorolac and aspirin on hemostasis in the rabbit]C M Samama, M Daghfous, S Delaporte-Cerceau, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2006
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancerG Simonneau, S Laporte, P Mismetti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasmaGrigoris T Gerotziafas, Ismail Elalamy, François Depasse, et al.
La Revue De Medecine Interne|January 1, 1997
[Severe hemorrhagic complications during treatment with low molecular weight heparin. Apropos of 2 cases]G Grateau, L Chauvenet, S Oudard, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1975
[Chronic pulmonary artery thrombosis. Therapeutic modality. Apropos of 6 cases]J Acar, C Cabrol, M Samama, et al.
Thrombosis Research|April 23, 2003
Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteersF Depasse, M J González de Suso, I Lagoutte, et al.
Pageof 68

Showing results (531-540 of 677) with videos related to

Sort By:
Pageof 68
Revue Des Maladies Respiratoires|November 8, 2005
[Antithrombotic therapy for venous thromboembolism - report of the 7th Conference of The American College of Chest Physicians]A Achkar, M-H Horellou, F Parent, et al.
Annales De Biologie Clinique|October 17, 2001
[Influence of oral anticoagulant treatment on D-dimers levels]E Ombandza-Moussa, M M Samama, M H Horellou, et al.
Anesthesia and Analgesia|May 29, 2001
Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood groupC Huraux, A Ankri A, D Eyraud, et al.
Thrombosis and Haemostasis|October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapyP Y Scarabin, G Plu-Bureau, L Bara, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1995
[Comparison of the effects of ketorolac and aspirin on hemostasis in the rabbit]C M Samama, M Daghfous, S Delaporte-Cerceau, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2006
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancerG Simonneau, S Laporte, P Mismetti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasmaGrigoris T Gerotziafas, Ismail Elalamy, François Depasse, et al.
La Revue De Medecine Interne|January 1, 1997
[Severe hemorrhagic complications during treatment with low molecular weight heparin. Apropos of 2 cases]G Grateau, L Chauvenet, S Oudard, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1975
[Chronic pulmonary artery thrombosis. Therapeutic modality. Apropos of 6 cases]J Acar, C Cabrol, M Samama, et al.
Thrombosis Research|April 23, 2003
Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteersF Depasse, M J González de Suso, I Lagoutte, et al.
Pageof 68